A 4mg dose means something completely different depending on whether your vial contains 5,000 mcg/mL or 10,000 mcg/mL
As more non-weight indications emerge, including potential applications for addiction, Alzheimer disease, fatty liver disease, and chronic kidney disease, the relevance of BMI as the primary gatekeeper will diminish
As discussed below, the development of unimolecular multi-agonists that stimulate GLP-1 receptors and other receptors such as GIP receptors and glucagon receptors (GCGR) can have beneficial effects on metabolism and increase metabolic rate at tolerable doses [57]
This step allows MEDVi physicians to determine eligibility for GLP-1 treatment and ensure medical suitability
Others use GLP-1 treatment as a bridge to establish healthier habits and then taper off gradually
(Chief Medical Advisor, dual board-certified Obesity Medicine/Internal Medicine)